首页 > 最新文献

JAMA surgery最新文献

英文 中文
Rizedisben Must Address Tumor-Nerve Co-Imaging for Clinical Translation. Rizedisben必须解决肿瘤-神经联合成像的临床翻译问题。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6026
Lingling Meng,Yupeng Di
{"title":"Rizedisben Must Address Tumor-Nerve Co-Imaging for Clinical Translation.","authors":"Lingling Meng,Yupeng Di","doi":"10.1001/jamasurg.2025.6026","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6026","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"3 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preempting the Trough of Disillusionment in Surgical AI. 外科人工智能的幻灭低谷。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6035
Jayson S Marwaha,Daniel A Hashimoto
{"title":"Preempting the Trough of Disillusionment in Surgical AI.","authors":"Jayson S Marwaha,Daniel A Hashimoto","doi":"10.1001/jamasurg.2025.6035","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6035","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"20 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expectations vs Reality of an Intraoperative Artificial Intelligence Intervention. 术中人工智能干预的期望与现实。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6029
Melissa Thornton,Benjamin A Y Cher,Cameron Macdonald,Jocelyn G Baker,Elisa L Marten,Don Mai,Ganesh Sankaranarayanan,Courtney J Balentine
ImportanceHaving significant gaps between the expectations and reality of artificial intelligence-based programs can be a major barrier to successful implementation. This is the first multisite implementation assessment of gaps between surgeon expectations and real-world effects of the Operating Room Black Box, a novel intervention that leverages artificial intelligence to improve surgical outcomes.ObjectiveTo identify barriers and facilitators to implementing artificial intelligence-based interventions that improve intra- and postoperative care.Design, Setting, and ParticipantsThis qualitative study was conducted at 3 large academic centers via semistructured interviews with surgeons and implementation leaders of the AI intervention to identify areas where expectations of the technology misaligned with their experiences. Thirty surgeons and 17 implementation leaders from 3 centers that implemented the AI intervention were interviewed. Data were collected and analyzed between 2021 and 2024.ExposureImplementation of the AI intervention.Main Outcomes and MeasuresThe primary outcome was areas of misalignment between participant expectations of the AI intervention technology and actual program deliverables.ResultsOf 30 surgeons and 17 implementation leaders interviewed, most surgeons (17 [57%]) were between the ages of 35 and 50 years, and implementation leaders were older, typically between 51 and 80 years old (6 [35%]). Eight surgeons (27%) and 4 implementation leaders (24%) were female. Most surgeons (17 [57%]) had neutral views of the technology, 11 (37%) expressed positive views, and 2 (7%) had negative views. Interviewees identified the following 4 major themes that highlighted misalignment between user expectations and the experience of using the technology: (1) the artificial intelligence model needed considerable additional training to be usable; (2) accessing data on surgical cases was difficult and time consuming; (3) the program showed limited ability to predict postoperative complications; and (4) the program generated few academic deliverables.Conclusions and RelevancePer the results of this multisite qualitative study, successfully implementing interventions based on artificial intelligence may require deliberate efforts to minimize gaps between what surgeons expect from the interventions and what they can deliver. Our evaluation of this study's AI intervention offers lessons for addressing this critical barrier to implementation.
在基于人工智能的项目的期望和现实之间存在重大差距可能是成功实施的主要障碍。这是第一次对外科医生期望与手术室黑匣子实际效果之间差距的多地点实施评估,手术室黑匣子是一种利用人工智能改善手术结果的新型干预措施。目的确定实施基于人工智能的干预措施以改善手术内和术后护理的障碍和促进因素。设计、环境和参与者本定性研究在3个大型学术中心进行,通过对外科医生和人工智能干预实施负责人进行半结构化访谈,以确定对技术的期望与他们的经验不一致的领域。访谈了来自3个实施人工智能干预的中心的30名外科医生和17名实施负责人。在2021年至2024年期间收集并分析了数据。曝光人工智能干预的实施。主要结果和措施主要结果是参与者对人工智能干预技术的期望与实际项目可交付成果之间的不一致领域。结果访谈的30名外科医生和17名实施领导中,年龄在35 ~ 50岁之间的外科医生最多(17名[57%]),实施领导年龄较大(6名[35%]),年龄在51 ~ 80岁之间。8名外科医生(27%)和4名执行负责人(24%)为女性。大多数外科医生(17位[57%])对该技术持中立态度,11位(37%)持积极态度,2位(7%)持消极态度。受访者确定了以下4个主要主题,突出了用户期望与使用该技术的体验之间的不一致:(1)人工智能模型需要大量额外的培训才能使用;(2)获取手术病例数据困难且耗时;(3)该程序预测术后并发症的能力有限;(4)该项目产生的学术成果很少。结论和相关性根据这项多地点定性研究的结果,成功实施基于人工智能的干预可能需要精心的努力,以最大限度地减少外科医生对干预的期望与他们所能提供的之间的差距。我们对这项研究的人工智能干预的评估为解决这一实施的关键障碍提供了经验教训。
{"title":"Expectations vs Reality of an Intraoperative Artificial Intelligence Intervention.","authors":"Melissa Thornton,Benjamin A Y Cher,Cameron Macdonald,Jocelyn G Baker,Elisa L Marten,Don Mai,Ganesh Sankaranarayanan,Courtney J Balentine","doi":"10.1001/jamasurg.2025.6029","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6029","url":null,"abstract":"ImportanceHaving significant gaps between the expectations and reality of artificial intelligence-based programs can be a major barrier to successful implementation. This is the first multisite implementation assessment of gaps between surgeon expectations and real-world effects of the Operating Room Black Box, a novel intervention that leverages artificial intelligence to improve surgical outcomes.ObjectiveTo identify barriers and facilitators to implementing artificial intelligence-based interventions that improve intra- and postoperative care.Design, Setting, and ParticipantsThis qualitative study was conducted at 3 large academic centers via semistructured interviews with surgeons and implementation leaders of the AI intervention to identify areas where expectations of the technology misaligned with their experiences. Thirty surgeons and 17 implementation leaders from 3 centers that implemented the AI intervention were interviewed. Data were collected and analyzed between 2021 and 2024.ExposureImplementation of the AI intervention.Main Outcomes and MeasuresThe primary outcome was areas of misalignment between participant expectations of the AI intervention technology and actual program deliverables.ResultsOf 30 surgeons and 17 implementation leaders interviewed, most surgeons (17 [57%]) were between the ages of 35 and 50 years, and implementation leaders were older, typically between 51 and 80 years old (6 [35%]). Eight surgeons (27%) and 4 implementation leaders (24%) were female. Most surgeons (17 [57%]) had neutral views of the technology, 11 (37%) expressed positive views, and 2 (7%) had negative views. Interviewees identified the following 4 major themes that highlighted misalignment between user expectations and the experience of using the technology: (1) the artificial intelligence model needed considerable additional training to be usable; (2) accessing data on surgical cases was difficult and time consuming; (3) the program showed limited ability to predict postoperative complications; and (4) the program generated few academic deliverables.Conclusions and RelevancePer the results of this multisite qualitative study, successfully implementing interventions based on artificial intelligence may require deliberate efforts to minimize gaps between what surgeons expect from the interventions and what they can deliver. Our evaluation of this study's AI intervention offers lessons for addressing this critical barrier to implementation.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"30 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of Eliminating Medicare's Inpatient Only List. 取消医疗保险住院病人名单的影响。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6067
Julia H Song,Patricia L Turner,Thomas C Tsai
{"title":"Implications of Eliminating Medicare's Inpatient Only List.","authors":"Julia H Song,Patricia L Turner,Thomas C Tsai","doi":"10.1001/jamasurg.2025.6067","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6067","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"177 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis. 降低BRCA1和BRCA2变异携带者双侧乳房切除术风险和死亡率:一项系统综述和荟萃分析。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-07 DOI: 10.1001/jamasurg.2025.5929
Cathal O'Reilly,Jennifer L McGarry,Alexandra M Zaborowski,Matthew G Davey,Denis Evoy,Jane Rothwell,Damian McCartan,Claire L Rutherford,Michael R Boland,Ruth S Prichard
ImportanceRisk-reducing bilateral mastectomy reduces the incidence of breast cancer in female carriers of the BRCA pathogenic variants, but its association with mortality remains uncertain.ObjectiveTo evaluate the association between risk-reducing bilateral mastectomy and overall and breast cancer-specific mortality in female carriers of BRCA pathogenic variants.Data SourcesPubMed, Scopus, CINAHL, Embase, and CENTRAL were searched in May 2025, with English-language restriction and no date limit. Reference lists of included studies and relevant reviews were also examined.Study SelectionEligible studies compared female carriers of BRCA1 and BRCA2 pathogenic variants who underwent risk-reducing bilateral mastectomy with those who did not and reported overall mortality or breast cancer-specific mortality. Studies including patients with a history of breast cancer were excluded.Data Extraction and SynthesisThis meta-analysis followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Two authors independently performed study selection, data extraction, and risk of bias assessment (using Risk of Bias in Nonrandomized Studies-of Interventions, version 2). Odds ratios (ORs) and hazard ratios (HRs) were pooled using fixed- and random-effects models according to methodological assessment.Main Outcomes and MeasuresOverall and breast cancer-specific mortality.ResultsSix observational studies met the inclusion criteria, comprising 6135 carriers of the BRCA1 or BRCA2 variant. Weighted median age at inclusion was 38.0 years, with reported age ranges spanning 15.3 to 85.3 years. Risk-reducing bilateral mastectomy was associated with lower overall mortality in both unadjusted (OR, 0.38; 95% CI, 0.27-0.55; P < .001) and adjusted (HR, 0.37; 95% CI, 0.23-0.60; P < .001) analyses. Breast cancer-specific mortality was also reduced (OR, 0.19; 95% CI, 0.08-0.47; P < .001; HR, 0.14; 95% CI, 0.04-0.49; P = .002).Conclusions and RelevanceRisk-reducing bilateral mastectomy was associated with lower overall and breast cancer-specific mortality in carriers of the BRCA variants. These findings support the role of risk-reducing bilateral mastectomy as a potentially life-extending intervention and may inform the shared decision-making discussions in these women.
降低风险的双侧乳房切除术降低了BRCA致病变异女性携带者的乳腺癌发病率,但其与死亡率的关系仍不确定。目的评估降低风险的双侧乳房切除术与BRCA致病变异女性携带者的总体死亡率和乳腺癌特异性死亡率之间的关系。数据源pubmed, Scopus, CINAHL, Embase和CENTRAL于2025年5月检索,有英文限制,无日期限制。还审查了纳入研究的参考清单和相关综述。研究选择:符合条件的研究比较了BRCA1和BRCA2致病变异的女性携带者,她们接受了降低风险的双侧乳房切除术,并报告了总死亡率或乳腺癌特异性死亡率。有乳腺癌病史的患者被排除在外。本荟萃分析遵循流行病学观察性研究荟萃分析(MOOSE)指南。两位作者独立进行了研究选择、数据提取和偏倚风险评估(使用《非随机研究干预的偏倚风险》,版本2)。根据方法学评估,采用固定效应和随机效应模型汇总优势比(ORs)和风险比(hr)。主要结局和测量:总体死亡率和乳腺癌特异性死亡率。结果6项观察性研究符合纳入标准,包括6135名BRCA1或BRCA2变异携带者。纳入时的加权中位年龄为38.0岁,报告的年龄范围为15.3至85.3岁。降低风险的双侧乳房切除术与两组患者较低的总死亡率相关(OR, 0.38; 95% CI, 0.27-0.55; P <。0.001)和调整后(HR, 0.37; 95% CI, 0.23-0.60; P <。001)分析。乳腺癌特异性死亡率也降低(OR, 0.19; 95% CI, 0.08-0.47; P < .001; HR, 0.14; 95% CI, 0.04-0.49; P = .002)。结论和相关性:降低风险的双侧乳房切除术与BRCA变异携带者较低的总体死亡率和乳腺癌特异性死亡率相关。这些发现支持降低风险的双侧乳房切除术作为一种潜在的延长生命的干预措施的作用,并可能为这些妇女的共同决策讨论提供信息。
{"title":"Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis.","authors":"Cathal O'Reilly,Jennifer L McGarry,Alexandra M Zaborowski,Matthew G Davey,Denis Evoy,Jane Rothwell,Damian McCartan,Claire L Rutherford,Michael R Boland,Ruth S Prichard","doi":"10.1001/jamasurg.2025.5929","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.5929","url":null,"abstract":"ImportanceRisk-reducing bilateral mastectomy reduces the incidence of breast cancer in female carriers of the BRCA pathogenic variants, but its association with mortality remains uncertain.ObjectiveTo evaluate the association between risk-reducing bilateral mastectomy and overall and breast cancer-specific mortality in female carriers of BRCA pathogenic variants.Data SourcesPubMed, Scopus, CINAHL, Embase, and CENTRAL were searched in May 2025, with English-language restriction and no date limit. Reference lists of included studies and relevant reviews were also examined.Study SelectionEligible studies compared female carriers of BRCA1 and BRCA2 pathogenic variants who underwent risk-reducing bilateral mastectomy with those who did not and reported overall mortality or breast cancer-specific mortality. Studies including patients with a history of breast cancer were excluded.Data Extraction and SynthesisThis meta-analysis followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Two authors independently performed study selection, data extraction, and risk of bias assessment (using Risk of Bias in Nonrandomized Studies-of Interventions, version 2). Odds ratios (ORs) and hazard ratios (HRs) were pooled using fixed- and random-effects models according to methodological assessment.Main Outcomes and MeasuresOverall and breast cancer-specific mortality.ResultsSix observational studies met the inclusion criteria, comprising 6135 carriers of the BRCA1 or BRCA2 variant. Weighted median age at inclusion was 38.0 years, with reported age ranges spanning 15.3 to 85.3 years. Risk-reducing bilateral mastectomy was associated with lower overall mortality in both unadjusted (OR, 0.38; 95% CI, 0.27-0.55; P < .001) and adjusted (HR, 0.37; 95% CI, 0.23-0.60; P < .001) analyses. Breast cancer-specific mortality was also reduced (OR, 0.19; 95% CI, 0.08-0.47; P < .001; HR, 0.14; 95% CI, 0.04-0.49; P = .002).Conclusions and RelevanceRisk-reducing bilateral mastectomy was associated with lower overall and breast cancer-specific mortality in carriers of the BRCA variants. These findings support the role of risk-reducing bilateral mastectomy as a potentially life-extending intervention and may inform the shared decision-making discussions in these women.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"391 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145907801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suitability of Large Language Models and Predicting Case Duration-Reply. 大型语言模型的适用性与案例持续时间预测。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-07 DOI: 10.1001/jamasurg.2025.5847
Anai N Kothari
{"title":"Suitability of Large Language Models and Predicting Case Duration-Reply.","authors":"Anai N Kothari","doi":"10.1001/jamasurg.2025.5847","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.5847","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"82 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145907803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suitability of Large Language Models and Predicting Case Duration. 大型语言模型的适用性与案例持续时间预测。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-07 DOI: 10.1001/jamasurg.2025.5844
Jordan Prosky,Judy Wawira Gichoya
{"title":"Suitability of Large Language Models and Predicting Case Duration.","authors":"Jordan Prosky,Judy Wawira Gichoya","doi":"10.1001/jamasurg.2025.5844","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.5844","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"39 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145907798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Table. 表中出现错误。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1001/jamasurg.2025.5476
{"title":"Error in Table.","authors":"","doi":"10.1001/jamasurg.2025.5476","DOIUrl":"10.1001/jamasurg.2025.5476","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":"104"},"PeriodicalIF":14.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12658749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145604020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total Pancreatectomy-Still a Last-Resort Procedure. 全胰切除术-仍然是最后的手段。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1001/jamasurg.2025.4916
Kaelyn C Cummins, Allan Tsung
{"title":"Total Pancreatectomy-Still a Last-Resort Procedure.","authors":"Kaelyn C Cummins, Allan Tsung","doi":"10.1001/jamasurg.2025.4916","DOIUrl":"10.1001/jamasurg.2025.4916","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":"58"},"PeriodicalIF":14.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145495553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Change to Open Access. 更改为开放获取。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-01 DOI: 10.1001/jamasurg.2025.5416
{"title":"Change to Open Access.","authors":"","doi":"10.1001/jamasurg.2025.5416","DOIUrl":"10.1001/jamasurg.2025.5416","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":"104"},"PeriodicalIF":14.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12631564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145549136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1